canada\s valeant buys eye firm bauschlomb for 87bn
Last Updated : GMT 05:17:37
Emiratesvoice, emirates voice
Emiratesvoice, emirates voice
Last Updated : GMT 05:17:37
Emiratesvoice, emirates voice

Canada\'s Valeant buys eye firm Bausch & Lomb for $8.7bn

Emiratesvoice, emirates voice

Emiratesvoice, emirates voice Canada\'s Valeant buys eye firm Bausch & Lomb for $8.7bn

Ottawa - AFP

Canadian pharmaceutical company Valeant announced Monday a deal to acquire US eye health company Bausch & Lomb for $8.7 billion in cash, becoming a behemoth in the burgeoning eye care sector. The acquisition, which had been rumored, positions Valeant to capitalize on \"growing eye health trends driven by an aging patient population, an increased rate of diabetes and demand from emerging markets,\" said a joint statement. The merger also gives Valeant access to Bausch & Lomb\'s large portfolio of products and \"a late stage pipeline of innovative, new products.\" \"With this transaction, Valeant will be a worldwide leader in both dermatology and eye health,\" Valeant\'s chief executive Michael Pearson summarized. Founded in 1853, privately held Bausch & Lomb, based in Rochester, New York, is best known for its contact lenses and for products related to maintaining contact lenses, such as PureVision, Optima and ReNu. The company also manufactures eye drops for treating eye dryness, glaucoma or allergies and materials used in eye surgery. The purchase of Bausch & Lomb by Valeant Pharmaceuticals International, Inc. follows a series of some 15 recent acquisitions by the Canadian company over the last year totaling $3.5 billion. But Bausch & Lomb is a far bigger target, enabling the Canadian firm to double its revenues in one fell swoop. The US company, which employs 11,200 worldwide, last year reported revenues of around $3 billion, according to a filing with US securities regulators. Valeant reported revenues of $3.3 billion and had about 7,000 employees at the end of 2012. Both companies had losses for 2012, with Bausch & Lomb reporting a loss of $68.3 million and Valeant a loss of $116 million. The potential Bausch & Lomb deal comes on the heels of Valeant\'s reportedly unsuccessful bid to buy US pharmaceutical company Actavis for more than $13 billion. The transaction also replaces a plan launched in March for Bausch & Lomb to undertake an initial public offering. Valeant said the transaction will be financed with debt and approximately $1.5 billion to $2.0 billion of new equity. Of the purchase price, $4.5 billion will go to an investor group led by Warburg Pincus and approximately $4.2 billion will be used to repay Bausch & Lomb\'s outstanding debt. Bausch & Lomb will retain its name and become a division of Valeant while Valeant\'s existing ophthalmology businesses will be integrated into the Bausch & Lomb division. The transaction, which is expected to close in the third quarter, is subject to closing conditions and regulatory approvals.

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

canada\s valeant buys eye firm bauschlomb for 87bn canada\s valeant buys eye firm bauschlomb for 87bn

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

canada\s valeant buys eye firm bauschlomb for 87bn canada\s valeant buys eye firm bauschlomb for 87bn

 



GMT 05:11 2011 Sunday ,31 July

Recognizing voices difficult for dyslexics

GMT 09:05 2016 Thursday ,24 March

Joy for India after one-run rollercoaster T20 win

GMT 09:43 2018 Tuesday ,23 January

Now is the time to revive King’s beautiful struggle

GMT 08:06 2017 Saturday ,29 July

UAE orders banks to freeze accounts,

GMT 00:14 2017 Monday ,30 October

UN rapporteur urges Iran to stop harassing BBC

GMT 21:23 2017 Saturday ,19 August

Singer Asala reveals details of her new song

GMT 11:43 2017 Tuesday ,17 January

The tomes of time

GMT 16:46 2012 Sunday ,10 June

Plant Experiment Garden to reopen in Rabat

GMT 10:27 2016 Monday ,10 October

Sharjah Department of eGovernment Reveals Design

GMT 09:29 2017 Tuesday ,28 February

Protesters sue to stop US missile system in S. Korea
 
 Emirates Voice Facebook,emirates voice facebook  Emirates Voice Twitter,emirates voice twitter Emirates Voice Rss,emirates voice rss  Emirates Voice Youtube,emirates voice youtube  Emirates Voice Youtube,emirates voice youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

emiratesvoieen emiratesvoiceen emiratesvoiceen emiratesvoiceen
emiratesvoice emiratesvoice emiratesvoice
emiratesvoice
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
emiratesvoice, Emiratesvoice, Emiratesvoice